Pathomorphological changes in the lung tissues of Syrian hamsters during experimental infection with SARS‐COV‐2
https://doi.org/10.18470/1992-1098-2024-3-5
Abstract
The new coronavirus infection caused by SARS‐CoV‐2 is a dangerous respiratory disease. The aim of the investigation was to study the pathomorphological changes in lungs of Syrian hamsters infected with SARS‐CoV‐2 as is necessary for adequate therapy and prevention of the disease.
Syrian hamsters of the SPF category were infected intranasally with a dose of 5×105TCID50 SARS‐CoV‐2/human/RUS/Nsk‐FRCFTM‐1/2020). Animals were euthanised on days 3, 6, 10, 14 and 21 after infection and the lungs were collected. To determine virus replication real‐time RT‐PCR was used. The lungs was used for histological examination. Statistics was performed using Statistics for Windows 10 software.
Specific pathological lesions characterising the inflammatory process were detected in all groups of animals. The severity of pathological changes and the volume of lung tissue lesions varied depending on the stage of the disease. The most severe lesions were observed on days 6–10. By day 21, the process of organ structure restoration was noticed.
The study showed that pathological changes in the Syrian hamster’s lungs caused by experimental infection with the SARS‐CoV‐2 were multifaceted and complex. In mild cases, congestion and infiltration are observed, and in severe cases, atelectasis and pulmonary edema were life‐threatening. The most severe lesions in lungs were noted on days 6–10. By day 21, the process of restoration was observed.
About the Authors
L. V. ShestopalovaRussian Federation
Lidia V. Shestopalova, PhD in Biology, Professor
2 Pirogova St, Novosibirsk region, Novosibirsk, 630090. Теl. +79059308065
Competing Interests:
The authors declare no conflict of interest
W. Lee
Russian Federation
Wang Lee
Novosibirsk
Competing Interests:
The authors declare no conflict of interest
A. Yu. Filippova
Russian Federation
Anastasia Yu. Filippova
Novosibirsk
Competing Interests:
The authors declare no conflict of interest
M. S. Fedotova
Russian Federation
Marina S. Fedotova
Novosibirsk
Competing Interests:
The authors declare no conflict of interest
Yu. V. Kononova
Russian Federation
Yulia V. Kononova
Novosibirsk
Competing Interests:
The authors declare no conflict of interest
M. A. Gulyaeva
Russian Federation
Marina A. Gulyaeva
Novosibirsk
Competing Interests:
The authors declare no conflict of interest
References
1. COVID‐19 Map – Johns Hopkins Coronavirus Resource Center. Accessed February 9, 2021. Accessed: https://coronavirus.jhu.edu/map.html
2. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus‐Infected Pneumonia in Wuhan, China. JAMA, 2020, vol. 323(11), pp. 1061–1069. doi: 10.1001/jama.2020.1585
3. Chan J.F., Zhang A.J., Yuan S. et al. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID‐ 19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2020, vol. 71(9), pp. 2428–2446. doi: 10.1093/cid/ciaa325
4. Bi Z., Hong W., Yang J., Lu S., Peng X. Animal models for SARS‐ CoV‐2 infection and pathology. MedComm, 2021, vol. 2(4), pp. 548–568. doi: 10.1002/mco2.98
5. Gupta U., Prakash A., Sachdeva S., Pangtey G.S., Khosla A., Aggarwal R., Sud R., Margekar S.L. COVID‐19 and Tuberculosis: A Meeting of Two Pandemics! J Assoc Physicians India. 2020, vol. 68(12), pp. 69–72.
6. Bussani R., Zentilin L., Correa R., Colliva A., Silvestri F., Zacchigna S., Collesi C., Giacca M. Persistent SARS‐CoV‐2 infection in patients seemingly recovered from COVID‐19. J Pathol., 2023, vol. 259(3), pp. 254–263. doi: 10.1002/path.6035
7. Lee J.H., Koh J., Jeon Y.K., Goo J.M., Yoon S.H. An Integrated Radiologic‐Pathologic Understanding of COVID‐19 Pneumonia. Radiology, 2023, vol. 306(2), article id: e222600. doi: 10.1148/radiol.222600
8. Omarova Zh.R., Pershina E.S., Samsonova M.V., Shchekochikhin D.Yu., Pereshivaylov S.O., Chernyaev A.L., Berezhnaya E.E., Parshin V.V., Tumanov V.P. Targeted morphological characteristics of the lungs in COVID‐19 based on computed tomography. Volgogradskii nauchno‐meditsinskii zhurnal [Volgograd scientific and medical journal]. 2022, no. 1, pp. 22–28. (In Russian)
9. Khodosh E.M., Ivakhno I.V., Efremova O.A., Obolonkova N.I., Golivets T.P., Khamnagadaev I.I. Clinical and pathomorphological patterns of diffuse alveolar damage caused by COVID‐19, in patients requiring respiratory support. Current problems of medicine, 2022, vol. 45, no. 1, pp. 39–54. (In Russian) DOI: 10.52575/2687‐0940‐2022‐45‐1‐39‐54
10. Sagidullin R.Kh., Khalikov A.A., Nazmieva A.R., Kuznetsov K.O., Kartoeva H.V. Pathological picture of COVID‐19. Forensic medicine, 2022, vol. 8, no. 1, pp. 41–50. (In Russian) https://doi.org/10.17816/fm421
Review
For citations:
Shestopalova L.V., Lee W., Filippova A.Yu., Fedotova M.S., Kononova Yu.V., Gulyaeva M.A. Pathomorphological changes in the lung tissues of Syrian hamsters during experimental infection with SARS‐COV‐2. South of Russia: ecology, development. 2024;19(3):55-62. (In Russ.) https://doi.org/10.18470/1992-1098-2024-3-5